Xierong Wei Selected Research

HIV Seropositivity

6/2014

Sensitive tenofovir resistance screening of HIV-1 from the genital and blood compartments of women with breakthrough infections in the CAPRISA 004 tenofovir gel trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xierong Wei Research Topics

Disease

3	Infections 01/2019 - 01/2010
1	HIV Infections (HIV Infection) 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2014
1	Breakthrough Infections 06/2014
1	HIV Seropositivity 06/2014

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2010
1	cabotegravirIBA 01/2019
1	Tenofovir (Viread)FDA Link 06/2014
1	Reverse Transcriptase InhibitorsIBA 03/2011
1	NucleosidesIBA 03/2011
1	BuffersIBA 01/2010
1	AntigensIBA 01/2010
1	AntibodiesIBA 01/2010